BlackRock Inc. purchased a new stake in shares of Metacrine, Inc. (NASDAQ:MTCR) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 88,821 shares of the company’s stock, valued at approximately $906,000. BlackRock Inc. owned about 0.34% of Metacrine at the end of the most recent reporting period. Separately, M&T Bank...
Read Full StoryRelated
Coronavirus tally: Global cases of COVID-19 top 95.6 million and U.S. approaches 400,000 fatalities
, 8min
0
Biden Picks Pa.'s Dr. Levine to Be Assistant Health Secretary, Would Make History If Confirmed
, 9min
0
Early administration of ivermectin could help reduce viral transmission in COVID-19 patients
, 11min
0
, 11min
0
Disease-prevention-and-treatment
Hamilton’s hospital flu cases at ‘unprecedented’ low levels
, 12min
0
Disease-prevention-and-treatment
A breakthrough discovery could reverse Motor Neurone Disease damage
, 14min
0
, 14min
0